Immunohistochemical examination of FFPE (formalin fixed paraffin embedded) PCa tissues of patients treated by different anti-androgen therapies showed an over-expression of PSMA after therapy in 55% of primary tumour samples and 100% of metastatic lesions compared to the baseline [37]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.